These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15116266)

  • 41. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use.
    Legnani C; Palareti G; Guazzaloca G; Cosmi B; Lunghi B; Bernardi F; Coccheri S
    Eur Heart J; 2002 Jun; 23(12):984-90. PubMed ID: 12069454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prothrombin G20210A and factor V Leiden polymorphisms in stroke.
    They-They TP; Battas O; Slassi I; Rafai MA; Katumbay DT; Nadifi S
    J Mol Neurosci; 2012 Jan; 46(1):210-6. PubMed ID: 21701789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
    Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke.
    Martinelli I; Battaglioli T; Burgo I; Di Domenico S; Mannucci PM
    Haematologica; 2006 Jun; 91(6):844-7. PubMed ID: 16769590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prothrombin G20210A mutation is associated with young-onset stroke: the genetics of early-onset stroke study and meta-analysis.
    Jiang B; Ryan KA; Hamedani A; Cheng Y; Sparks MJ; Koontz D; Bean CJ; Gallagher M; Hooper WC; McArdle PF; O'Connell JR; Stine OC; Wozniak MA; Stern BJ; Mitchell BD; Kittner SJ; Cole JW
    Stroke; 2014 Apr; 45(4):961-7. PubMed ID: 24619398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factor v Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke.
    Simchen MJ; Goldstein G; Lubetsky A; Strauss T; Schiff E; Kenet G
    Stroke; 2009 Jan; 40(1):65-70. PubMed ID: 18927445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor V leiden and ischemic stroke risk: the Genetics of Early Onset Stroke (GEOS) study.
    Hamedani AG; Cole JW; Cheng Y; Sparks MJ; O'Connell JR; Stine OC; Wozniak MA; Stern BJ; Mitchell BD; Kittner SJ
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):419-23. PubMed ID: 22100829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stroke in an infant heterozygous carrier of both Factor V G1691A and the G20210A prothrombin mutation.
    Germanakis I; Stiakaki E; Sfyridaki C; Katampekios S; Danilatou V; Kalmanti M
    Thromb Haemost; 2003 Oct; 90(4):760-3. PubMed ID: 14515201
    [No Abstract]   [Full Text] [Related]  

  • 51. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factor V Leiden and prothrombin G20210A in Portuguese women with recurrent miscarriage: is it worthwhile to investigate?
    Serrano F; Lima ML; Lopes C; Almeida JP; Branco J
    Arch Gynecol Obstet; 2011 Nov; 284(5):1127-32. PubMed ID: 21259017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of ischemic stroke in young Indians: is thrombophilia profiling a way out?
    Chatterjee T; Gupta N; Choudhry VP; Behari M; Saxena R; Ashraf MZ
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):449-53. PubMed ID: 23337710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
    Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determinants of premature familial arterial thrombosis in patients with juvenile ischaemic stroke. The Italian Project on Stroke in Young Adults (IPSYS).
    Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Bonifati DM; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Spalloni A; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Rasura M; Simone AM; Gamba M; Cerrato P; Micieli G; Melis M; Massucco D; De Giuli V; Pepe D; Iacoviello L; Padovani A;
    Thromb Haemost; 2015 Mar; 113(3):641-8. PubMed ID: 25413729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS; Singh MP; Yadav R
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? Systematic review and meta-analysis.
    Pezzini A; Grassi M; Zotto ED; Giossi A; Volonghi I; Costa P; Grau A; Magoni M; Padovani A; Lichy C
    Thromb Haemost; 2009 May; 101(5):813-7. PubMed ID: 19404532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5,000 patients.
    Kocher O; Cirovic C; Malynn E; Rowland CM; Bare LA; Young BA; Henslee JG; Laffler TG; Huff JB; Kruskall MS; Wong G; Bauer KA
    Am J Clin Pathol; 2007 Jan; 127(1):68-75. PubMed ID: 17145624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.